Reinvestigation of methotrexate metabolism in rodents

Chloroquinoxaline sulfonamide: a sulfanilamide antitumor agent entering clinical trials.

Investigational new drugs·1993

Cyclopentenyl cytosine: interspecies predictions based on rodent plasma and urine kinetics.

Investigational new drugs·1991

Could interspecies differences in the protein binding of flavone acetic acid contribute to the failure to predict lack of efficacy in patients?

Cancer chemotherapy and pharmacology·1989

Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2.

Journal of immunology (Baltimore, Md. : 1950)·1988

Flavone acetic acid (LM 975, NSC 347512). A novel antitumor agent.

Cancer chemotherapy and pharmacology·1987

Therapeutic and pharmacokinetic relationships of flavone acetic acid: an agent with activity against solid tumors.

Cancer treatment reports·1986

The role of spatial transcriptomics in exploring the tumor microenvironment in neuroblastoma.

Biochemical pharmacology·2026

Lipid regulation of mitochondrial function in metabolic Diseases: Lipotoxic mediators and therapeutic targeting.

Biochemical pharmacology·2026

circ_0043837 attenuates macrophage mitochondrial damage through XPO1-associated HuR transport in atherosclerosis.

Biochemical pharmacology·2026

PTEN-Long-mediated molecular therapy: current evidences and future perspectives.

Biochemical pharmacology·2026

Transcriptional and epigenetic regulation of ferroptosis in cancer drug resistance: Mechanisms and targeted therapeutic opportunities.

Biochemical pharmacology·2026

Ambrisentan rescues doxorubicin-induced cardiac apoptosis and mitochondrial bioenergetic dysfunction: Mechanistic insights into p53 and mTOR signaling.

Biochemical pharmacology·2026

Integrated Multi-Tissue Omics Identifies Acylcarnitine Accumulation as Shared Metabolic Marker of Diabetic Microangiopathy With Cross-Organ Validation.

Investigative ophthalmology & visual science·2026

Gut microbiota-derived metabolites and host interactions in fibrotic diseases: mechanisms, cross-organ signatures, and therapeutic opportunities.

Frontiers in microbiology·2026

Direct comparison of serine restriction on the viability of normal and cancer cells demonstrates that methionine restriction is more cancer specific.

Frontiers in oncology·2026

Mitophagy as an active regulator of cardiac metabolic reprogramming.

Frontiers in cardiovascular medicine·2026

Regulatory mechanisms and interactions of mitophagy and ketone body metabolism in cardiac metabolism.

Frontiers in cardiovascular medicine·2026

The Methionine-Mitochondria Axis in Cancer: Metabolic Cross-Talk and Therapeutic Vulnerabilities.

Current pharmacology reports·2026

Related Experiment Videos

Reinvestigation of methotrexate metabolism in rodents

Related Concept Videos

Chloroquinoxaline sulfonamide: a sulfanilamide antitumor agent entering clinical trials.

Cyclopentenyl cytosine: interspecies predictions based on rodent plasma and urine kinetics.

Could interspecies differences in the protein binding of flavone acetic acid contribute to the failure to predict lack of efficacy in patients?

Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2.

Flavone acetic acid (LM 975, NSC 347512). A novel antitumor agent.

Therapeutic and pharmacokinetic relationships of flavone acetic acid: an agent with activity against solid tumors.

The role of spatial transcriptomics in exploring the tumor microenvironment in neuroblastoma.

Lipid regulation of mitochondrial function in metabolic Diseases: Lipotoxic mediators and therapeutic targeting.

circ_0043837 attenuates macrophage mitochondrial damage through XPO1-associated HuR transport in atherosclerosis.

PTEN-Long-mediated molecular therapy: current evidences and future perspectives.

Transcriptional and epigenetic regulation of ferroptosis in cancer drug resistance: Mechanisms and targeted therapeutic opportunities.

Ambrisentan rescues doxorubicin-induced cardiac apoptosis and mitochondrial bioenergetic dysfunction: Mechanistic insights into p53 and mTOR signaling.

Integrated Multi-Tissue Omics Identifies Acylcarnitine Accumulation as Shared Metabolic Marker of Diabetic Microangiopathy With Cross-Organ Validation.

Gut microbiota-derived metabolites and host interactions in fibrotic diseases: mechanisms, cross-organ signatures, and therapeutic opportunities.

Direct comparison of serine restriction on the viability of normal and cancer cells demonstrates that methionine restriction is more cancer specific.

Mitophagy as an active regulator of cardiac metabolic reprogramming.

Regulatory mechanisms and interactions of mitophagy and ketone body metabolism in cardiac metabolism.

The Methionine-Mitochondria Axis in Cancer: Metabolic Cross-Talk and Therapeutic Vulnerabilities.

Related Experiment Videos

Reinvestigation of methotrexate metabolism in rodents

Related Concept Videos

Related Articles